Publication | Closed Access

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

Bone DiseaseBone HealthGynecologyLow Bone MassMenopauseBone DensityMedicineOsteoporosisBone MetabolismRheumatoid ArthritisWomen's HealthPostmenopausal Women